Poly(lactic acid)/β-cyclodextrin based nanoparticles bearing ruthenium(II)-arene naproxen complex : preparation and characterisation. Analytical validation for metal determination by microwave-induced plasma optical emission spectrometry
The objectives of this work are to develop nanocarrier systems for the Ru(II)-p-cymene naproxen antitumor metallodrug, [Ru(η6-p-cymene)(npx)Cl] or Rupcy, based on polymeric nanoparticles (NPs) composed by the biodegradable poly(lactic acid) (PLA) and the hydrophilic polymerised β-cyclodextrin (PolyCD); to validate an analytical method for determination of Ru incorporated into the metallodrug loaded-NPs. The PolyCD was prepared by single step condensation and polymerisation reaction and incorporated as a polymer blend during the fabrication of PLA/PolyCD blends NPs and also as a core/shell structure built by adsorption of the PolyCD onto the surface of PLA NPs to give PLA(core)/PolyCD(shell) NPs. Three different loaded-systems incorporating the metallodrug (Rupcy-PLA NPs (1), Rupcy-PLA/PolyCD blends (2), and Rupcy-PLA(core)/PolyCD(shell) NPs (3)) were prepared by nanoprecipitation. The characterisation was performed by Proton Nuclear Magnetic Resonance, Matrix Assisted Laser Desorption/Ionization Time-of-Flight, Fourier-Transform Infra-red and UV-VIS Electronic Absorption Spectroscopies, Thermogravimetric Analysis, Differential Scanning Calorimetry, Dynamic Light Scattering, and Electrophoretic Light Scattering. Ru was determined by Microwave Induced Plasma Optical Emission Spectrometry (MIP-OES) with validation of the method. The metallodrug entrapment efficiency was around 90% (w/w) and drug loading was at 3-4% (w/w). The characterised metallodrug-loaded systems exhibited monomodal size distributions and appropriate hydrodynamic diameters [218.3 ± 13.5 (1), 205.4 ± 14.4 (2), 231.5 ± 22.0 (3) nm] and zeta potential values [-31.5 ± 2.2 (1), -26.1 ± 4.5 (2), -28.8 ± 6.1 (3) mV]. The validation of the MIP-OES method by evaluating selectivity, linearity, precision, accuracy, and limits of detection and quantification succeeded. The NPs parameters are compatible with colloidally stable systems. The MIP-OES method showed to be simple, reliable, and feasible to quantify indirectly the amount of the metallodrug-loaded into the PLA NPs.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
---|---|
Enthalten in: |
Journal of microencapsulation - 40(2023), 2 vom: 03. März, Seite 67-81 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Reis Nascimento, Ruan [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 27.03.2023 Date Revised 27.03.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/02652048.2023.2172469 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM352330465 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM352330465 | ||
003 | DE-627 | ||
005 | 20231226053455.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/02652048.2023.2172469 |2 doi | |
028 | 5 | 2 | |a pubmed24n1174.xml |
035 | |a (DE-627)NLM352330465 | ||
035 | |a (NLM)36722704 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Reis Nascimento, Ruan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Poly(lactic acid)/β-cyclodextrin based nanoparticles bearing ruthenium(II)-arene naproxen complex |b preparation and characterisation. Analytical validation for metal determination by microwave-induced plasma optical emission spectrometry |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 27.03.2023 | ||
500 | |a Date Revised 27.03.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a The objectives of this work are to develop nanocarrier systems for the Ru(II)-p-cymene naproxen antitumor metallodrug, [Ru(η6-p-cymene)(npx)Cl] or Rupcy, based on polymeric nanoparticles (NPs) composed by the biodegradable poly(lactic acid) (PLA) and the hydrophilic polymerised β-cyclodextrin (PolyCD); to validate an analytical method for determination of Ru incorporated into the metallodrug loaded-NPs. The PolyCD was prepared by single step condensation and polymerisation reaction and incorporated as a polymer blend during the fabrication of PLA/PolyCD blends NPs and also as a core/shell structure built by adsorption of the PolyCD onto the surface of PLA NPs to give PLA(core)/PolyCD(shell) NPs. Three different loaded-systems incorporating the metallodrug (Rupcy-PLA NPs (1), Rupcy-PLA/PolyCD blends (2), and Rupcy-PLA(core)/PolyCD(shell) NPs (3)) were prepared by nanoprecipitation. The characterisation was performed by Proton Nuclear Magnetic Resonance, Matrix Assisted Laser Desorption/Ionization Time-of-Flight, Fourier-Transform Infra-red and UV-VIS Electronic Absorption Spectroscopies, Thermogravimetric Analysis, Differential Scanning Calorimetry, Dynamic Light Scattering, and Electrophoretic Light Scattering. Ru was determined by Microwave Induced Plasma Optical Emission Spectrometry (MIP-OES) with validation of the method. The metallodrug entrapment efficiency was around 90% (w/w) and drug loading was at 3-4% (w/w). The characterised metallodrug-loaded systems exhibited monomodal size distributions and appropriate hydrodynamic diameters [218.3 ± 13.5 (1), 205.4 ± 14.4 (2), 231.5 ± 22.0 (3) nm] and zeta potential values [-31.5 ± 2.2 (1), -26.1 ± 4.5 (2), -28.8 ± 6.1 (3) mV]. The validation of the MIP-OES method by evaluating selectivity, linearity, precision, accuracy, and limits of detection and quantification succeeded. The NPs parameters are compatible with colloidally stable systems. The MIP-OES method showed to be simple, reliable, and feasible to quantify indirectly the amount of the metallodrug-loaded into the PLA NPs | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Metallodrug | |
650 | 4 | |a anti-inflammatory drugs | |
650 | 4 | |a biodegradable polymers | |
650 | 4 | |a drug delivery systems | |
650 | 4 | |a microwave-induced plasma | |
650 | 7 | |a poly(lactide) |2 NLM | |
650 | 7 | |a 459TN2L5F5 |2 NLM | |
650 | 7 | |a 4-cymene |2 NLM | |
650 | 7 | |a 1G1C8T1N7Q |2 NLM | |
650 | 7 | |a Naproxen |2 NLM | |
650 | 7 | |a 57Y76R9ATQ |2 NLM | |
650 | 7 | |a Ruthenium |2 NLM | |
650 | 7 | |a 7UI0TKC3U5 |2 NLM | |
650 | 7 | |a Polyesters |2 NLM | |
650 | 7 | |a Polymers |2 NLM | |
650 | 7 | |a Drug Carriers |2 NLM | |
700 | 1 | |a Pauline Gaitan Tabares, Julie |e verfasserin |4 aut | |
700 | 1 | |a Marques Dos Anjos, Paulo Neilson |e verfasserin |4 aut | |
700 | 1 | |a Santos, Luana Novaes |e verfasserin |4 aut | |
700 | 1 | |a de Oliveira Silva, Denise |e verfasserin |4 aut | |
700 | 1 | |a Silva Ribeiro Santos, Rodrigo Luis |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of microencapsulation |d 1989 |g 40(2023), 2 vom: 03. März, Seite 67-81 |w (DE-627)NLM013098217 |x 1464-5246 |7 nnns |
773 | 1 | 8 | |g volume:40 |g year:2023 |g number:2 |g day:03 |g month:03 |g pages:67-81 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/02652048.2023.2172469 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 40 |j 2023 |e 2 |b 03 |c 03 |h 67-81 |